Preclinical studies of noncharged oxime reactivators for organophosphate exposure.
about
Discovery of New Classes of Compounds that Reactivate Acetylcholinesterase Inhibited by OrganophosphatesNovel approaches to mitigating parathion toxicity: targeting cytochrome P450-mediated metabolism with menadione.Recent advances in acetylcholinesterase Inhibitors and Reactivators: an update on the patent literature (2012-2015).The biodistribution and pharmacokinetics of the oxime acetylcholinesterase reactivator RS194B in guinea pigs.
P2860
Preclinical studies of noncharged oxime reactivators for organophosphate exposure.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Preclinical studies of noncharged oxime reactivators for organophosphate exposure.
@en
Preclinical studies of noncharged oxime reactivators for organophosphate exposure.
@nl
type
label
Preclinical studies of noncharged oxime reactivators for organophosphate exposure.
@en
Preclinical studies of noncharged oxime reactivators for organophosphate exposure.
@nl
prefLabel
Preclinical studies of noncharged oxime reactivators for organophosphate exposure.
@en
Preclinical studies of noncharged oxime reactivators for organophosphate exposure.
@nl
P2093
P2860
P356
P1476
Preclinical studies of noncharged oxime reactivators for organophosphate exposure.
@en
P2093
Emily Smith
John R Cashman
Karl J Okolotowicz
Mary Dwyer
P2860
P356
10.1002/JBT.21519
P577
2013-08-13T00:00:00Z